课题基金 / 基金详情

Characterization of immunogenic and structural properties of HIV-1 envelope

Characterization of immunogenic and structural properties of HIV-1 envelope
HIV-1 包膜的免疫原性和结构特性的表征
批准号:
8260556
负责人:
Michael W Cho
金额:
$95.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-05-01 至 2014-04-30

项目摘要

项目成果

Michael W Cho的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is a global urgency to develop a protective vaccine against HIV-1. Neutralizing antibodies (Nabs) can provide effective prophylaxis against HIV-1 infections. However, eliciting Nabs that are broadly cross-reactive against many antigenically diverse HIV-1 isolates has been a major challenge and it remains a critical roadblock to HIV-1 vaccine development. The primary objective of the studies being proposed is to generate novel antigens that are able to elicit such Nabs, with a long-term goal of developing a vaccine against the virus. The underlying hypothesis of this proposal is that we will be able to enhance immunogenicity of key epitopes that can elicit broadly reactive Nabs by altering the antigenic composition of HIV-1 envelope protein, as long as the immunogen is structurally intact and the epitopes are antigenically correct. To test this hypothesis, we have generated prototypic antigens based on gp41 membrane-proximal external region (MPER) and gp120 outer domain (gp120OD). Both proteins are immunogenic and can elicit Nabs against multiple primary HIV-1 isolates. Our goal is to use current and evolving understanding of biochemical, structural and immunogenic properties of the prototypic antigens to design second-generation antigens that could induce even more potent Nabs. The proposed studies are focused and hypothesis-driven, with clearly defined milestones and timelines. Successful completion of the proposed studies would represent a major advancement towards developing a protective AIDS vaccine. The proposed research Program consists of two Projects and one Core: The role of Project 1 is to design subunit envelope antigens, to produce them, and to evaluate their immunogenic properties. The role of Project 2 is to determine high-resolution structures of the antigens with a goal of facilitating the antigen design process and understanding of their immunological properties. The Administrative Core is responsible for providing the organizational management and maintaining infrastructure to support the fiscal monitoring.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1186/s12977-014-0125-5
发表时间: 2014-12-20
期刊: Retrovirology
影响因子: 3.3
作者: [Qin Y, Shi H, Banerjee S, Agrawal A, Banasik M, Cho MW]
通讯作者: Cho MW
Structural analysis of a highly glycosylated and unliganded gp120-based antigen using mass spectrometry.
使用质谱法对高度糖基化且未配体的基于 gp120 的抗原进行结构分析。
DOI: 10.1021/bi1011332
发表时间: 2010
期刊: Biochemistry
影响因子: 2.9
作者: [Wang,Liwen, Qin,Yali, Ilchenko,Serguei, Bohon,Jen, Shi,Wuxian, Cho,MichaelW, Takamoto,Keiji, Chance,MarkR]
通讯作者: Chance,MarkR
DOI: 10.1371/journal.pone.0128823
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者: [Qin Y, Banerjee S, Agrawal A, Shi H, Banasik M, Lin F, Rohl K, LaBranche C, Montefiori DC, Cho MW]
通讯作者: Cho MW
Eliciting neutralizing antibodies with gp120 outer domain constructs based on M-group consensus sequence.
使用基于 M 组共有序列的 gp120 外域构建体引发中和抗体。
DOI: 10.1016/j.virol.2014.06.006
发表时间: 2014
期刊: Virology
影响因子: 3.7
作者: [Qin,Yali, Banasik,Marisa, Kim,SoonJeung, Penn-Nicholson,Adam, Habte,HabtomH, LaBranche,Celia, Montefiori,DavidC, Wang,Chong, Cho,MichaelW]
通讯作者: Cho,MichaelW
Induction of bnAbs against HIV-1 gp41.
  • 批准号:
    10603692
  • 项目类别:
  • 资助金额:
    $29.73万
  • 财政年份:
    2022
  • 负责人:
    Michael W Cho
  • 依托单位:
Development of a vaccine strategy using antibody-complexed antigens
  • 批准号:
    9161293
  • 项目类别:
  • 资助金额:
    $22.04万
  • 财政年份:
    2016
  • 负责人:
    Michael W Cho
  • 依托单位:
Vaccines Against Antigenically Variable Viruses Symposium
  • 批准号:
    9065323
  • 项目类别:
  • 资助金额:
    $0.75万
  • 财政年份:
    2015
  • 负责人:
    Michael W Cho
  • 依托单位:
Enhancing B cell immunity against HIV-1 using novel vaccine delivery platforms
  • 批准号:
    8310163
  • 项目类别:
  • 资助金额:
    $124.56万
  • 财政年份:
    2010
  • 负责人:
    Michael W Cho
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究